AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Rowley, M Bristow, LJ Hutson, PH
Citation: M. Rowley et al., Current and novel approaches to the drug treatment of schizophrenia, J MED CHEM, 44(4), 2001, pp. 477-501

Authors: Rowley, M Hallett, DJ Goodacre, S Moyes, C Crawforth, J Sparey, TJ Patel, S Marwood, R Patel, S Thomas, S Hitzel, L O'Connor, D Szeto, N Castro, JL Hutson, PH MacLeod, AM
Citation: M. Rowley et al., 3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist, J MED CHEM, 44(10), 2001, pp. 1603-1614

Authors: Hjorth, S Hutson, PH
Citation: S. Hjorth et Ph. Hutson, Introduction - Neuroregulation of serotoninergic systems: basic and clinical perspectives, J PSYCHOPH, 14(2), 2000, pp. 99-99

Authors: Atack, JR Cook, SM Hutson, PH File, SE
Citation: Jr. Atack et al., Kindling induced by pentylenetetrazole in rats is not directly associated with changes in the expression of NMDA or benzodiazepine receptors, PHARM BIO B, 65(4), 2000, pp. 743-750

Authors: Bristow, LJ O'Connor, D Watts, R Duxon, MS Hutson, PH
Citation: Lj. Bristow et al., Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat, NEUROPHARM, 39(7), 2000, pp. 1222-1236

Authors: Hutson, PH Barton, CL Jay, M Blurton, P Burkamp, F Clarkson, R Bristow, LJ
Citation: Ph. Hutson et al., Activation of mesolimbic dopamine function by phencyclidine is enhanced by5-HT2C/2B receptor antagonists: neurochemical and behavioural studies, NEUROPHARM, 39(12), 2000, pp. 2318-2328

Authors: Grimwood, S Richards, P Murray, F Harrison, N Wingrove, PB Hutson, PH
Citation: S. Grimwood et al., Characterisation of N-methyl-D-aspartate receptor-specific[H-3]ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes, J NEUROCHEM, 75(6), 2000, pp. 2455-2463

Authors: Murray, F Kennedy, J Hutson, PH Elliot, J Huscroft, I Mohnen, K Russell, MGN Grimwood, S
Citation: F. Murray et al., Modulation of [H-3]MK-801 binding to NMDA receptors in vivo and in vitro, EUR J PHARM, 397(2-3), 2000, pp. 263-270

Authors: Grimwood, S Slater, P Deakin, JFW Hutson, PH
Citation: S. Grimwood et al., NR2B-containing NMDA receptors are upregulated in temporal cortex in schizophrenia, NEUROREPORT, 10(3), 1999, pp. 461-465

Authors: Sardar, AM Hutson, PH Reynolds, GP
Citation: Am. Sardar et al., Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS, NEUROREPORT, 10(17), 1999, pp. 3513-3515

Authors: Barton, CL Hutson, PH
Citation: Cl. Barton et Ph. Hutson, Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: Evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors, SYNAPSE, 31(1), 1999, pp. 13-19
Risultati: 1-11 |